France has chosen Boehringer Ingelheim, a German laboratory, to provide up to 80 million doses of avian flu vaccine for ducks starting in October. The vaccination campaign aims to reduce viral excretion, slow down transmission, and control the risk to human health. Boehringer Ingelheim was chosen because it can meet the needs of vaccinating both mule ducks and Muscovy ducks, and if the decision is made to vaccinate all year round, a new order of vaccines will be placed.